| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a717ea5b2ac78ac329ab3a9659d834d2 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D241-08 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D241-08 |
| filingDate |
1971-07-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1973-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4728104e2e420fbb419119679bc2122e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_53fa7ba393c296d54716944b60b9fe78 |
| publicationDate |
1973-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-3749725-A |
| titleOfInvention |
Substituted 3,3-diphenylpiperazines and 3,3-diphenylpiperazin-2-ones |
| abstract |
THE DISCLOSURE IS DIRECTED TO SUBSTITUTED 3,3-DIPHENYLPIPERAZINES, SUBSTITUTED 3,3-DIPHENYLPIPERAZIN-2-ONES AND RELATED COMPOUNDS. THE COMPOUNDS ARE USEFUL AS SYMPATHOMIMETIC AGENTS AS EVIDENCED BY THEIR PRODUCTION OF MYDRIASIS IN STANDARD LABORATORY ANIMALS. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003050316-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5110929-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010324064-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7786147-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6881738-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005227993-A1 |
| priorityDate |
1968-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |